Table 1 Baseline characteristics of the patients with CTEPH
|  | CTEPH (n = 135) |
|---|---|
Age (years) | 64 (52–70) |
Male/female, n | 27/108 |
Body weight (kg) | 52.9 (48.0–60.4) |
BMI (kg/m2) | 21.6 (20.0–23.8) |
WHO-FC (I: II: III: IV) | 10:74:50:1 |
Type (occult/recurrent) | 80/55 |
Hb (g/dL) | 13.8 (12.6–14.8) |
BNP (pg/mL) | 86.3 (29.2–288) |
CRP (g/dL) | 0.1 (0.1–0.2) |
ATIII (%) | 99 (89.8–109) |
Systolic blood pressure (mmHg) | 124 (110–142) |
Diastolic blood pressure (mmHg) | 73 (63–82) |
mPAP (mmHg) | 43 (35–51) |
PVR (dyne sec cm−5) | 689 (482–983) |
RAP (mmHg) | 8.0 (6.0–11.5) |
CO (L/min) | 3.90 (3.37–4.61) |
CI (L/min/m2) | 2.53 (2.18–2.95) |
PaO2 (mmHg) | 56 (51.8–65.9) |
PaCO2 (mmHg) | 37.7 (34.3–42.7) |
PvO2 (mmHg) | 33.8 (31.1–35.9) |
SvO2 (%) | 62.7 (58.5–68.5) |
AaDO2 (mmHg) | 48.0 (39.9–53.4) |
6MWD (m) | 369 (306–424) |
CTA obstruction score | 26 (18–34) |